A mononitrophenol that is 2-nitrophenol and its derivatives resulting from substitution of one or more of the hydrogens attached to the benzene ring by a non-nitro group.
ChEBI ID: 86421
| Member | Definition | Role |
|---|---|---|
| 2-nitrophenol | A member of the class of 2-nitrophenols that is phenol in which one of the hydrogens that is ortho to the hydroxy group has been replaced by a nitro group. | 2-nitrophenol |
| 3-nitrotyrosine | A nitrotyrosine comprising tyrosine having a nitro group at the 3-position on the phenyl ring. | 3-nitrotyrosine |
| 4-amino-2-nitrophenol | 4-Amino-2-nitrophenol | |
| 4-hydroxy-3-nitrophenylacetyl-o-succinimide ester | The ester formed between N-hydroxysuccinimide and (4-hydroxy-3-nitrophenyl)acetic acid. | 1-((4-hydroxy-3-nitrophenyl)acetoxy)pyrrolidine-2,5-dione |
| entacapone | A monocarboxylic acid amide that is N,N-diethylprop-2-enamide in which the hydrogen at position 2 is substituted by a cyano group and the hydrogen at the 3E position is substituted by a 3,4-dihydroxy-5-nitrophenyl group. | entacapone |
| nitrohydroxyiodophenylacetate | A member of the class of phenylacetic acids that is phenylacetic acid in which the phenyl group is substituted by iodo, hydroxy and nitro groups at positions 3, 4 and 5 respectively. | (4-hydroxy-3-iodo-5-nitrophenyl)acetic acid |
| roxarsone | An organoarsonic acid where the organyl group is 4-hydroxy-3-nitrophenyl. | roxarsone |
| tolcapone | Benzophenone substituted on one of the phenyl rings at C-3 and C-4 by hydroxy groups and at C-5 by a nitro group, and on the other phenyl ring by a methyl group at C-4. It is an inhibitor of catechol O-methyltransferase. | tolcapone |
| Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
|---|---|---|
| pre-1990 | 125 (2.74) | 18.7374 |
| 1990's | 498 (10.90) | 18.2507 |
| 2000's | 2,132 (46.67) | 29.6817 |
| 2010's | 1,598 (34.98) | 24.3611 |
| 2020's | 215 (4.71) | 2.80 |
| Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
|---|---|---|
| Trials | 282 (5.79%) | 5.53% |
| Reviews | 262 (5.38%) | 6.00% |
| Case Studies | 49 (1.01%) | 4.05% |
| Observational | 4 (0.08%) | 0.25% |
| Other | 4,270 (87.73%) | 84.16% |